The Ministry of Health, through the Pharmacy and Poisons Board (PPB), has recommended the registration of Lenacapavir, a long-acting HIV prevention drug, for use in Kenya. The drug includes Lenacapavir 300 mg tablets and Lenacapavir 464 mg injection. It is used for HIV pre-exposure prophylaxis (PrEP), which helps prevent HIV infection in people who are [...] The post Kenya Moves to Approve Long-Acting HIV Prevention Drug Lenacapavir appeared first on Kahawatungu .